A physical therapist was shocked to learn that for her, some of her crucial organs had an expiration date. With proactive ...

Currently, doctors sometimes use a drug called spironolactone to treat this condition. It’s a medication that’s been around ...

Compare Dialysis Centers examined CDC data and other sources to explore kidney disease risk factors and why the condition has ...

Researchers from the University of Kentucky have taken a closer look at the relationship between obesity and kidney disease ...

Chronic kidney disease is a major public health issue in India, leading to 45% deaths due to kidney failure between 2018 and ...

Discover how your kidneys and blood pressure are secretly linked, plus 6 vital strategies to protect both systems and prevent ...

The pharma will pay $800 million for the biotech, which was launched nearly two decades ago by Alnylam and Ionis to advance ...

Orphan drug specialist Amicus Therapeutics is paying Dimerix $30 million cash for U.S. rights to the phase 3 prospect DMX-200 ...

"Understanding the impact of fat-derived signals will pave the way for innovative therapies that can prevent or slow the progression of kidney disease in individuals with obesity," said Loria.

Tolvaptan is indicated to slow kidney function decline in adults at risk of rapidly progressing autosomal dominant polycystic kidney disease. “We are very pleased to have obtained approval for ...